Loading...
Header Logo
Keywords
Last Name
Institution

Kai Ding

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentBiostatistics & Epidemiology
Address801 NE 13th St
Oklahoma City OK 73104-5005
Phone405/271-2229
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of North Carolina, Chapel Hill, NCPhD2010Biostatistics

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L, Fung KM, Zheng W, Allard FD, Yee EU, Ding K, Wu H, Liang Z, Zheng L, Fernandez-Zapico ME, Li YP, Bronze MS, Morris KT, Postier RG, Houchen CW, Yang J, Li M. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Clin Cancer Res. 2018 Apr 03. PMID: 29615456.
      View in: PubMed
    2. Dockery LE, Motwani A, Ding K, Doescher M, Dvorak JD, Moore KN, Holman LL. Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough. Gynecol Oncol. 2018 Apr; 149(1):89-92. PMID: 29605056.
      View in: PubMed
    3. Alam K, Farasyn T, Ding K, Yue W. Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues. Drug Metab Lett. 2018 Mar 25. PMID: 29577869.
      View in: PubMed
    4. Alam K, Crowe A, Wang X, Zhang P, Ding K, Li L, Yue W. Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. Int J Mol Sci. 2018 Mar 14; 19(3). PMID: 29538325.
      View in: PubMed
    5. Alam K, Farasyn T, Crowe A, Ding K, Yue W. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. PLoS One. 2017; 12(11):e0186924. PMID: 29107984.
      View in: PubMed
    6. Sluch I, Gudgel B, Dvorak J, Anne Ahluwalia M, Ding K, Vold S, Sarkisian S. Clinical Experience with the M4 Ahmed Glaucoma Drainage Implant. J Curr Glaucoma Pract. 2017 Sep-Dec; 11(3):92-96. PMID: 29151683.
      View in: PubMed
    7. Dockery LE, Tew WP, Ding K, Moore KN. Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer. Gynecol Oncol. 2017 12; 147(3):509-513. PMID: 29037805.
      View in: PubMed
    8. Khaimi MA, Dvorak JD, Ding K. An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma. J Ophthalmol. 2017; 2017:2904272. PMID: 29098083.
      View in: PubMed
    9. Sluch IM, Elliott MS, Dvorak J, Ding K, Farris BK. Acetazolamide: A New Treatment for Visual Vertigo. Neuroophthalmology. 2017 Dec; 41(6):315-320. PMID: 29344071.
      View in: PubMed
    10. Greenwade MM, Moore KN, Gillen JM, Ding K, Rowland MR, Crim AK, Kleis B, Gunderson CC. Factors influencing clinical trial enrollment among ovarian cancer patients. Gynecol Oncol. 2017 09; 146(3):465-469. PMID: 28689668.
      View in: PubMed
    11. Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, Tsiokas L, Bhattacharya R, Mukherjee P. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 May 22; 8:14634. PMID: 28530221.
      View in: PubMed
    12. Rhoades DA, Hawkins M, Norton B, Branam D, Cannady TK, Dvorak J, Ding K, Olson AL, Doescher MP. Choctaw Nation Youth Sun Exposure Survey. Prev Med Rep. 2017 Sep; 7:7-10. PMID: 28540161.
      View in: PubMed
    13. Pahwa S, Alam K, Crowe A, Farasyn T, Neuhoff S, Hatley O, Ding K, Yue W. Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport. J Pharm Sci. 2017 Aug; 106(8):2123-2135. PMID: 28373111.
      View in: PubMed
    14. Banerjee Mustafi S, Chakraborty PK, Dwivedi SK, Ding K, Moxley KM, Mukherjee P, Bhattacharya R. BMI1, a new target of CK2a. Mol Cancer. 2017 03 07; 16(1):56. PMID: 28270146.
      View in: PubMed
    15. Gillen J, Gunderson C, Greenwade M, Rowland M, Ruskin R, Ding K, Crim A, Walter A, White E, Moore K. Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36. PMID: 28087143.
      View in: PubMed
    16. Nelson CE, Rayan GM, Judd DI, Ding K, Stoner JA. Survey of Hand and Upper Extremity Injuries Among Rock Climbers. Hand (N Y). 2017 Jul; 12(4):389-394. PMID: 28644933.
      View in: PubMed
    17. Robinson ME, Moreau A, O'Meilia R, Pagteilan J, Ding K, Siatkowski RM, Farris BK. The Relationship Between Optic Nerve Sheath Decompression Failure and Intracranial Pressure in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2016 09; 36(3):246-51. PMID: 27023308.
      View in: PubMed
    18. Gunderson CC, Ding K, Dvorak J, Moore KN, McMeekin DS, Benbrook DM. The pro-inflammatory effect of obesity on high grade serous ovarian cancer. Gynecol Oncol. 2016 10; 143(1):40-45. PMID: 27423378.
      View in: PubMed
    19. Campbell J, Gandhi K, Pate A, Janitz A, Anderson A, Kinnard R, Ding K. Five-Year Cancer Survival Rates in Oklahoma from 1997 to 2008. J Okla State Med Assoc. 2016 Jul-Aug; 109(7-8):318-332. PMID: 27890941.
      View in: PubMed
    20. Banerjee Mustafi S, Chakraborty PK, Naz S, Dwivedi SK, Street M, Basak R, Yang D, Ding K, Mukherjee P, Bhattacharya R. MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016 08; 1859(8):983-93. PMID: 27295567; PMCID: PMC4958591 [Available on 08/01/17].
    21. Gunderson CC, Walter AC, Ruskin R, Ding K, Moore KN. Post-intensive care unit syndrome in gynecologic oncology patients. Support Care Cancer. 2016 11; 24(11):4627-32. PMID: 27306212.
      View in: PubMed
    22. Wang Y, Thai T, Moore K, Ding K, McMeekin S, Liu H, Zheng B. Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients. Oncol Lett. 2016 Jul; 12(1):680-686. PMID: 27347200.
      View in: PubMed
    23. Slaughter K, Holman LL, Thomas EL, Gunderson CC, Lauer JK, Ding K, McMeekin DS, Moore KM. Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30. PMID: 27208536.
      View in: PubMed
    24. Alam K, Pahwa S, Wang X, Zhang P, Ding K, Abuznait AH, Li L, Yue W. Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions. Mol Pharm. 2016 Mar 07; 13(3):839-51. PMID: 26750564; PMCID: PMC4970216.
    25. Qiu Y, Tan M, McMeekin S, Thai T, Ding K, Moore K, Liu H, Zheng B. Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis. Acta Radiol. 2016 Sep; 57(9):1149-55. PMID: 26663390.
      View in: PubMed
    26. Sureban SM, Madhoun MF, May R, Qu D, Ali N, Fazili J, Weygant N, Chandrakesan P, Ding K, Lightfoot SA, Houchen CW. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15. PMID: 26468984; PMCID: PMC4741924.
    27. Zhang Q, Sun X, Yang J, Ding H, LeBrun D, Ding K, Houchen CW, Postier RG, Ambrose CG, Li Z, Bi X, Li M. ZIP4 silencing improves bone loss in pancreatic cancer. Oncotarget. 2015 Sep 22; 6(28):26041-51. PMID: 26305676; PMCID: PMC4694884.
    28. Sureban SM, May R, Qu D, Chandrakesan P, Weygant N, Ali N, Lightfoot SA, Ding K, Umar S, Schlosser MJ, Houchen CW. Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury. PLoS One. 2015; 10(8):e0135561. PMID: 26270561; PMCID: PMC4536042.
    29. Wendelboe AM, Campbell J, McCumber M, Bratzler D, Ding K, Beckman M, Reyes N, Raskob G. The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods. Am Heart J. 2015 Sep; 170(3):447-54.e18. PMID: 26385027; PMCID: PMC4598067.
    30. Chan AY, Conrady CD, Ding K, Dvorak JD, Stone DU. Factors associated with age of onset of herpes zoster ophthalmicus. Cornea. 2015 May; 34(5):535-40. PMID: 25710509.
      View in: PubMed
    31. Beck JK, Zhang Y, Shay CM, Muhamedagic CA, Sternlof SA, Ding K, Short MM, Dvorak JD, Lane JT. Diabetes knowledge in young adults: associations with hemoglobin A1C. Fam Syst Health. 2015 Mar; 33(1):28-35. PMID: 25603310.
      View in: PubMed
    32. Allan EJ, Khaimi MA, Jones JM, Ding K, Skuta GL. Long-term efficacy of the Baerveldt 250 mm2 compared with the Baerveldt 350 mm2 implant. Ophthalmology. 2015 Mar; 122(3):486-93. PMID: 25439594.
      View in: PubMed
    33. Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN. The survival detriment of venous thromboembolism with epithelial ovarian cancer. Gynecol Oncol. 2014 Jul; 134(1):73-7. PMID: 24793732.
      View in: PubMed
    34. Jetton JA, Ding K, Kim Y, Stone DU. Effects of tobacco smoking on human corneal wound healing. Cornea. 2014 May; 33(5):453-6. PMID: 24619165.
      View in: PubMed
    35. Slaughter KN, Thai T, Penaroza S, Benbrook DM, Thavathiru E, Ding K, Nelson T, McMeekin DS, Moore KN. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. Gynecol Oncol. 2014 Apr; 133(1):11-5. PMID: 24680585.
      View in: PubMed
    36. Adler E, Ding K, Siatkowski RM. Factors related to strabismus decompensation after a period of prolonged postoperative stability. J AAPOS. 2014 Feb; 18(1):50-5. PMID: 24568983.
      View in: PubMed
    37. Wiley KF, Ding K, Stoner JA, Teague DC, Yousuf KM. Incidence of pseudotumor and acute lymphocytic vasculitis associated lesion (ALVAL) reactions in metal-on-metal hip articulations: a meta-analysis. J Arthroplasty. 2013 Aug; 28(7):1238-45. PMID: 23660012.
      View in: PubMed
    38. Gaines LG, Fent KW, Flack SL, Thomasen JM, Ball LM, Richardson DB, Ding K, Whittaker SG, Nylander-French LA. Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI). Ann Occup Hyg. 2010 Aug; 54(6):678-91. PMID: 20530123; PMCID: PMC2918490.
    39. Carmichael SL, Herring AH, Sjödin A, Jones R, Needham L, Ma C, Ding K, Shaw GM. Hypospadias and halogenated organic pollutant levels in maternal mid-pregnancy serum samples. Chemosphere. 2010 Jul; 80(6):641-6. PMID: 20494400; PMCID: PMC2944405.
    40. Fent KW, Trelles Gaines LG, Thomasen JM, Flack SL, Ding K, Herring AH, Whittaker SG, Nylander-French LA. Quantification and statistical modeling--part II: dermal concentrations of monomeric and polymeric 1,6-hexamethylene diisocyanate. Ann Occup Hyg. 2009 Oct; 53(7):691-702. PMID: 19635734; PMCID: PMC2758669.
    41. Fent KW, Gaines LG, Thomasen JM, Flack SL, Ding K, Herring AH, Whittaker SG, Nylander-French LA. Quantification and statistical modeling--part I: breathing-zone concentrations of monomeric and polymeric 1,6-hexamethylene diisocyanate. Ann Occup Hyg. 2009 Oct; 53(7):677-89. PMID: 19622637; PMCID: PMC2758668.
    Ding's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _